NINDS Small Business Innovation Research / Small Business Technology Transfer

NINDS Small Business Innovation Research and Small Business Technology Transfer support U.S. small businesses that are moving neuroscience ideas toward commercialization. The program covers applied bench research, translational research, and early-stage clinical trials for tools and therapies tied to neurological disorders. The main mechanisms are R43/R44 for SBIR, R41/R42 for STTR, and U44 for a cooperative-agreement Phase II path. Applicants are asked to send a brief abstract or technology overview at least one month before the standard deadline, and the eligibility profile requires a U.S. for-profit company rather than an individual or nonprofit. NINDS frames the route as a commercialization path, with company showcase, awardee resources, FAQs, and success stories alongside the funding instructions. The best fit is a team building neuroscience products for areas such as neurological disorders, stroke, epilepsy, pain, or brain research. The program page also points applicants to the NIH small business set-aside and standard NIH due dates, which keep the cadence aligned with the rest of the institute's small business portfolio.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.